Literature DB >> 1369182

Optimal medium use for continuous high density perfusion processes.

H Büntemeyer1, C Wallerius, J Lehmann.   

Abstract

For maintenance of high cell density in continuous perfusion processes not only feeding with substrates but also removal of inhibitors and toxic waste products are of special interest. High perfusion rates cause large volumes of product containing medium which have to be processed in product isolation. In order to minimize these volumes concentrated feed solutions of optimized medium are used. On the other hand, such media may cause high concentrations of toxic or inhibitory metabolites which can negatively influence cell growth and product formation. Especially, if the spent medium (or special parts of it) is used again after product isolation, the removal or even better the control of inhibitor production is of highest importance. We have developed a continuous fermentation concept and system (continuous medium cycle bioreactor, cMCB) in which both limitation and inhibition effects can be generated to identify special substances as limiting or inhibitory components. With the results from those experiments it was possible to lower the total perfusion rate during serum-free perfusion cultures of hybridoma cells and to obtain an optimal substrate utilization. The advantages for decreasing the production costs (for media, special supplements and product isolation) are obvious. The other aim of this study was to identify secreted metabolic waste products as inhibitor or toxic metabolite.

Mesh:

Substances:

Year:  1992        PMID: 1369182     DOI: 10.1007/bf02521732

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  5 in total

1.  The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system.

Authors:  R Kempken; H Büntemeyer; J Lehmann
Journal:  Cytotechnology       Date:  1991-10       Impact factor: 2.058

2.  Growth limitation in hybridoma cell cultures: the role of inhibitory or toxic metabolites.

Authors:  O W Rønning; M Schartum; A Winsnes; G Lindberg
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

Review 3.  Hybridoma growth limitations: the roles of energy metabolism and ammonia production.

Authors:  M Newland; P F Greenfield; S Reid
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

4.  Optimization of serum-free fermentation processes for antibody production.

Authors:  H Büntemeyer; D Lütkemeyer; J Lehmann
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

5.  Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production.

Authors:  S S Ozturk; M R Riley; B O Palsson
Journal:  Biotechnol Bioeng       Date:  1992-02-20       Impact factor: 4.530

  5 in total
  4 in total

1.  Software sensors for the monitoring of perfusion cultures: evaluation of the hybridoma density and the medium composition from glucose concentration measurements.

Authors:  F Pelletier; C Fonteix; A L da Silva; A Marc; J M Engasser
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

2.  Change in growth kinetics of hybridoma cells entrapped in collagen gel affected by alkaline supply.

Authors:  Y Shirai; M Yamaguchi; A Kobayashi; A Nishi; H Nakamura; H Murakami
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

3.  Growth and interferon-gamma production in batch culture of CHO cells.

Authors:  V Leelavatcharamas; A N Emery; M al-Rubeai
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Significant inhibition of hybridoma cells by exogenous application of ganglioside GM3, a possible modulator of cell growth in vitro.

Authors:  H Brandt; J Müthing; J Peter-Katalinić; J Lehmann
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.